{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:39:34Z","timestamp":1792550374067,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303699"],"award-info":[{"award-number":["82303699"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32201127"],"award-info":[{"award-number":["32201127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270113"],"award-info":[{"award-number":["82270113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jcis.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:11:22Z","timestamp":1738599082000},"page":"1019-1032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["An albumin-prodrug injectable formulation for synergistic cancer immunotherapy"],"prefix":"10.1016","volume":"686","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuchen","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longguang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcis.2025.02.012_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.jcis.2025.02.012_b0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.jcis.2025.02.012_b0015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.jcis.2025.02.012_b0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/acs.accounts.2c00770","article-title":"Photothermal nanomaterial-mediated photoporation","volume":"56","author":"Xiong","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jcis.2025.02.012_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100036","article-title":"Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review","volume":"3","author":"Ma","year":"2024","journal-title":"Nano TransMed"},{"issue":"9","key":"10.1016\/j.jcis.2025.02.012_b0035","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/C9CS00839J","article-title":"Stimuli-responsive nanobubbles for biomedical applications","volume":"50","author":"Xiong","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.jcis.2025.02.012_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cgt.2015.11","article-title":"Oncolytic viruses: focusing on the tumor microenvironment","volume":"22","author":"de Vries","year":"2015","journal-title":"Cancer Gene Ther."},{"issue":"9","key":"10.1016\/j.jcis.2025.02.012_b0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jcis.2025.02.012_b0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-022-00951-x","article-title":"Engineering strategies to enhance oncolytic viruses in cancer immunotherapy","volume":"7","author":"Tian","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.jcis.2025.02.012_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-021-00574-0","article-title":"Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics","volume":"23","author":"Twomey","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.jcis.2025.02.012_b0065","unstructured":"Engineering strategies to enhance oncolytic viruses in cancer immunotherapy."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0070","doi-asserted-by":"crossref","DOI":"10.26599\/NTM.2023.9130018","article-title":"Nano-immunotherapy for lung cancer","volume":"2","author":"Lu","year":"2023","journal-title":"Nano TransMed"},{"issue":"4","key":"10.1016\/j.jcis.2025.02.012_b0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0080","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1038\/s41467-023-40312-y","article-title":"Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"issue":"7213","key":"10.1016\/j.jcis.2025.02.012_b0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41467-017-00573-w","article-title":"Signalling strength determines proapoptotic functions of STING","volume":"8","author":"Gulen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcis.2025.02.012_b0095","article-title":"Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of EGFR-mutant lung cancer","volume":"14","author":"Lin","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.jcis.2025.02.012_b0100","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323\u2032-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nrd.2017.264","article-title":"Can innate immune system targets turn up the heat on 'cold' tumours?","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.jcis.2025.02.012_b0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jcis.2025.02.012_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114020","article-title":"Delivery of STING agonists for adjuvanting subunit vaccines","volume":"179","author":"Van Herck","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6506","key":"10.1016\/j.jcis.2025.02.012_b0120","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6098","article-title":"An orally available non-nucleotide STING agonist with antitumor activity","volume":"369","author":"Pan","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jcis.2025.02.012_b0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41416-018-0188-5","article-title":"STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer","volume":"119","author":"Ghaffari","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcis.2025.02.012_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2020.11.049","article-title":"Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer","volume":"500","author":"Zhou","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"31","key":"10.1016\/j.jcis.2025.02.012_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302046","article-title":"Dual-targeting nanoliposome improves proinflammatory immunomodulation of the tumor microenvironment","volume":"12","author":"Gu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.jcis.2025.02.012_b0145","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s41591-021-01544-x","article-title":"A phase 1\/2 trial of an immune-modulatory vaccine against IDO\/PD-L1 in combination with nivolumab in metastatic melanoma","volume":"27","author":"Kjeldsen","year":"2021","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.jcis.2025.02.012_b0150","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 inhibitors: from bench to bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.jcis.2025.02.012_b0155","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-15-1456","article-title":"STING promotes the growth of tumors characterized by low antigenicity via IDO activation","volume":"76","author":"Lemos","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jcis.2025.02.012_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104384","article-title":"STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer","volume":"366","author":"Shi","year":"2021","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.jcis.2025.02.012_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105373","article-title":"Structure\u2010based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles","volume":"9","author":"De","year":"2022","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.jcis.2025.02.012_b0175","article-title":"Advanced bioactive nanomaterials for biomedical applications","volume":"1","author":"Zhao","year":"2021","journal-title":"Exploration (Beijing)"},{"issue":"47","key":"10.1016\/j.jcis.2025.02.012_b0180","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1002\/adma.201600038","article-title":"Albumin carriers for cancer theranostics: a conventional platform with new promise","volume":"28","author":"Chen","year":"2016","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.jcis.2025.02.012_b0185","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/17425247.2022.2134341","article-title":"Current trends in the use of human serum albumin for drug delivery in cancer","volume":"19","author":"Paul","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jcis.2025.02.012_b0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mattod.2020.11.015","article-title":"Protein-based nanomaterials and nanosystems for biomedical applications: A review","volume":"43","author":"Ding","year":"2021","journal-title":"Mater. Today"},{"issue":"25","key":"10.1016\/j.jcis.2025.02.012_b0195","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1080\/10408398.2022.2045471","article-title":"Bioactive compounds: Application of albumin nanocarriers as delivery systems","volume":"63","author":"Visentini","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12272-020-01204-7","article-title":"Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy","volume":"43","author":"Lamichhane","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jcis.2025.02.012_b0205","article-title":"Targeted delivery of albumin nanoparticles for breast cancer: A review","volume":"213","author":"Shalvi Sinai Kunde","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jcis.2025.02.012_b0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcis.2021.03.174","article-title":"High performance, environmentally friendly and sustainable nanofiber membrane filter for removal of particulate matter 1.0","volume":"597","author":"Cui","year":"2021","journal-title":"J. Colloid Interface Sci."},{"issue":"16","key":"10.1016\/j.jcis.2025.02.012_b0215","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.7150\/thno.98462","article-title":"Tau\u2011targeting multifunctional nanocomposite based on tannic acid-metal for near-infrared fluorescence\/magnetic resonance bimodal imaging-guided combinational therapy in Alzheimer's disease","volume":"14","author":"Gu","year":"2024","journal-title":"Theranostics"},{"issue":"20","key":"10.1016\/j.jcis.2025.02.012_b0220","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.biomaterials.2012.03.056","article-title":"Multidrug release based on microneedle arrays filled with pH-responsive PLGA hollow microspheres","volume":"33","author":"Ke","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcis.2025.02.012_b0225","first-page":"378","article-title":"MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis","volume":"37","author":"Zhou","year":"2024","journal-title":"Bioact. Mater."},{"issue":"49","key":"10.1016\/j.jcis.2025.02.012_b0230","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1021\/jacs.1c09155","article-title":"A tumor-targeting near-infrared heptamethine cyanine photosensitizer with twisted molecular structure for enhanced imaging-guided cancer phototherapy","volume":"143","author":"Zhao","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.jcis.2025.02.012_b0235","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41565-021-00950-z","article-title":"Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy","volume":"16","author":"Wang","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.012_b0240","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-023-00551-z","article-title":"Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Biomarker Res."},{"issue":"6","key":"10.1016\/j.jcis.2025.02.012_b0245","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.jcis.2025.02.012_b0250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","article-title":"Prolonged activation of innate immune pathways by a polyvalent STING agonist","volume":"5","author":"Li","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jcis.2025.02.012_b0255","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2020.68","article-title":"Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance","author":"Hassanin","year":"2020","journal-title":"Cancer Drug Resistance"},{"key":"10.1016\/j.jcis.2025.02.012_b0260","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.2147\/IJN.S467876","article-title":"Albumin nanoparticle-based drug delivery systems","volume":"19","author":"Qu","year":"2024","journal-title":"Int. J. Nanomed."}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979725003455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979725003455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:38:13Z","timestamp":1740821893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979725003455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"alternative-id":["S0021979725003455"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2025.02.012","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An albumin-prodrug injectable formulation for synergistic cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}